Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
- Status
- RECRUITING
- Phase
- N/A
Tumor Regression Grade As Predictor of Adjuvant Therapy
- Status
- RECRUITING
- Phase
- N/A
A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- NA
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study
- Status
- RECRUITING
- Phase
- PHASE3
A Study of BG-C477 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
- Status
- RECRUITING
- Phase
- PHASE3
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1